Low-dose aspirin slashed dementia risk by 70% in certain people, study shows. Researchers at Monash University in Australia went back to the ASPREE trial, a large study in which older adults took either a daily low-dose aspirin or a dummy pill (placebo). They analyzed the genetic data of more than 13,500 participants and gave each person a "polygenic score", a combined measure of many small gene variants, linked to how many platelets their blood makes. Platelets are the tiny cells that help blood clot. In the 20% of people with the highest platelet scores, just 1% of those on aspirin developed dementia, compared with 3.3% of those on placebo, about 70% lower risk. Earlier trials found aspirin didn't prevent dementia when everyone was considered together, so this points to a hidden group who might benefit, and to platelet biology as a new lead in dementia research. The signal wasn't tied to known Alzheimer's risk genes. But the same high-score group also had more major bleeding on aspirin, 4.4% vs 2.1% on placebo. This is a subgroup finding that still needs confirming in a dedicated trial. Do not start taking aspirin to prevent dementia on your own: daily aspirin can cause serious bleeding, so talk to your doctor first. source: Fransquet, P. D., Yu, C., Tran, C., Hussain, S. M., Brodtmann, A., Tonkin, A. M., Nelson, M. R., Ryan, J., McNeil, J. J., & Lacaze, P. (2026). Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementia. Alzheimer's & Dementia, 22(9).

A personalized mRNA vaccine cut the risk of melanoma coming back or death by 42% in a major trial. The trial, called INTerpath-001, enrolled 1,137 adults whose stage 2 to 4 melanoma had been surgically removed but who were at high risk of it coming back. All of them received pembrolizumab (Keytruda), a drug that helps the immune system attack cancer. About two-thirds also got the vaccine, which is made for each patient by reading the genetic code of their tumor and encoding up to 34 of its unique mutations in mRNA. That trains the immune system to hunt down any cancer cells left behind. After about two years, 82.2% of the vaccine group were still cancer-free, compared with 70.0% of those on the immunotherapy drug alone. Melanoma is the deadliest form of skin cancer, and this is the first time a personalized cancer vaccine has shown a clear benefit in a large, late-stage trial. The vaccine isn't approved yet, and it's too early to know if it helps people live longer, since survival data are still coming in. Side effects were mostly short-lived, like fever, sore arms and fatigue. source: Long, G. V., et al. (2026). INTerpath-001: Intismeran autogene plus pembrolizumab versus pembrolizumab alone for resected high-risk melanoma [Conference presentation]. ESMO Congress 2026.

Oral sex has overtaken smoking as the primary driver of throat cancer. In a significant shift in oncology, the human papillomavirus (HPV) has replaced tobacco and alcohol as the leading cause of oropharyngeal cancer. This specific strain, most commonly HPV-16, targets the tonsils and the back of the throat, where it can persist and replicate. While the body clears most HPV infections, persistent cases can trigger cellular changes that evolve into malignancy over time. Currently, HPV is responsible for approximately 70% to 85% of all throat cancer diagnoses in several Western nations, marking a public health turning point. Research indicates that the risk of contracting this cancer is directly linked to sexual history, as the virus is primarily transmitted through oral sex. Studies show that a higher number of lifetime sexual partners correlates with a greater risk of infection, with men being significantly more susceptible to oral HPV than women. Public health experts emphasize that HPV vaccination remains the most effective preventive measure, particularly when administered to young adults, alongside increased awareness of the risks associated with oral transmission. source: The Conversation. HPV-related throat cancer: Oral sex is now a leading risk factor. The Conversation.

🚨 A groundbreaking study reveals that the sperm cells carry biological ECHOES of a father's stress, particularly from childhood trauma

🚨: Scientists warn Al can plant false memories and it's slowly decaying your brain

🚨 What if the biggest change in human history isn’t a war, a discovery, or a new country—but the moment we connect our minds directly to machines? Futurist and Google computer scientist Ray Kurzweil believes that moment could arrive much sooner than most people expect. Kurzweil has spent decades predicting that technology will continue improving at an extraordinary pace. His latest timeline still points toward 2045 as the year he calls the technological “Singularity”—a point when artificial intelligence becomes so advanced that the relationship between humans and machines could fundamentally change. But the story may begin much earlier. Kurzweil predicts that Artificial General Intelligence (AGI)—AI capable of performing a broad range of intellectual tasks at a human level—could arrive around 2029. From there, he expects AI to improve rapidly, eventually becoming vastly more capable than biological intelligence. His vision goes far beyond today's chatbots. Kurzweil imagines humans eventually connecting their brains to advanced computer systems, allowing information to move between the human mind and the digital world at extremely high speeds. Instead of simply using a computer with our hands, we could one day interact with technology directly through our brains. And that could change what it means to be human. He argues that advances in genetics, nanotechnology, robotics, and artificial intelligence could eventually allow people to overcome many of the biological limits that have shaped humanity for thousands of years—including disease, aging and perhaps even the limits of the human brain itself. The most extreme part of his prediction is that AI could eventually become billions of times more powerful than the intelligence we associate with an individual human mind. If that happens, the future may no longer be controlled by biological evolution alone. Technology could begin changing humanity faster than natural evolution ever could. But there is an enormous question hiding underneath this optimistic vision: If we can merge our minds with machines, where does the human end—and the machine begin? Would enhanced humans still be human? Could digital intelligence become conscious? Who would control these technologies? And what happens to people who cannot—or do not want to—merge with them? Kurzweil remains deeply optimistic about this future, believing advanced technology could dramatically extend human lifespans and give people abilities that seem impossible today. Whether his 2045 prediction proves accurate remains unknown. But one thing is becoming harder to ignore: the boundary between humans and artificial intelligence is already beginning to blur. And if Kurzweil is right, the biggest technological revolution in history may not be about building smarter machines. It may be about turning ourselves into something new. Source: Ray Kurzweil, The Singularity Is Nearer: When We Merge with AI (Viking, 2024).

🚨: Scientists Used 40.68 MHz Ultrasound Waves to Boost Brain Waste Clearance and Flush Out Alzheimer’s-Linked Toxic Proteins in Just 10 Minutes

Particle accelerator experiments are helping scientists understand how matter can be created from energy through processes predicted by quantum physics. In quantum field theory, a vacuum is not simply empty space. Even when no real particles are present, quantum fields still exist and can exhibit fluctuations. One remarkable prediction is that sufficiently energetic photons can interact to produce a particle and its antiparticle. This process is known as the Breit–Wheeler mechanism, first described theoretically in 1934. In 2021, scientists working with the STAR detector at Brookhaven National Laboratory’s Relativistic Heavy Ion Collider reported evidence of this process. They studied near-miss collisions between gold nuclei traveling at almost the speed of light. The nuclei generated extremely powerful electromagnetic fields, allowing photons associated with those fields to interact. These interactions produced electron–positron pairs. Electrons are ordinary particles of matter, while positrons are their antimatter counterparts. The experiment demonstrated a fundamental relationship described by Einstein’s equation, E = mc²: energy can be converted into mass under the right physical conditions. Quantum physics also predicts that extremely strong electric fields can generate particle–antiparticle pairs through a related phenomenon called the Schwinger effect. Directly observing this effect in a pure vacuum remains an experimental challenge because the required electric fields are extraordinarily intense. These studies help physicists investigate the behavior of quantum fields, the relationship between matter and energy, and the fundamental properties of empty space. Source: Brookhaven National Laboratory; Physical Review Letters (2021); CERN.

Your Phone and Computer Are Getting More AI. Here’s How to Take Back Control! Your iPhone, Android phone, and Windows computer are quietly filling up with AI features you may never have asked for. From Apple Intelligence and Google Gemini to Microsoft Copilot, these tools are becoming part of everyday software. The good news? You can turn many of them off. On iPhones, visit Settings → Apple Intelligence & Siri. On Windows, check Copilot settings or uninstall its app. Android users can review Gemini settings and disable integrations where available. Want to go further? Linux offers an alternative to Windows, while the LibreWolf browser focuses on privacy and reducing unwanted tracking. AI can be useful, but it shouldn’t mean giving up control over your own devices. A few settings can help you build a simpler, less intrusive digital experience. Source: Morgan, T. (2026). How to Remove AI From Your Life. Which?

Nearly 1 in 4 People With Depression May Have a Hidden Biological Clock Problem A 2026 study published in The British Journal of Psychiatry has highlighted a possible subtype of major depression linked to disruptions in the body’s internal clock. Researchers suggest that this pattern may affect nearly 25% of people with severe or persistent depression, potentially helping explain why some patients struggle to find relief with standard treatments. People with this pattern may experience extreme morning tiredness, difficulty waking up, late-night sleep schedules, seasonal mood changes, and longer periods of sleep during depressive episodes. Their internal clocks may be out of sync with the natural day-night cycle, creating a condition that resembles living with constant jet lag. The discovery could help explain why the same antidepressant does not work equally well for everyone. Instead of relying on medication alone, some patients might benefit from treatments that help reset their biological rhythms, including carefully timed light exposure, structured sleep schedules, and medically guided melatonin use. Researchers are investigating how genetic differences and disrupted sleep patterns may help identify people who could benefit from these approaches. However, more research is needed to confirm how reliably this subtype can be identified and which treatments work best. The biggest takeaway? Depression may not follow the same biological pattern in everyone. Understanding a person’s internal body clock could eventually help doctors choose more personalized treatments for those who have struggled to get better. Source: Tonini, E., Crouse, J. J., & Hickie, I. B. (2026). Identification of a circadian subtype in major depressive disorder. The British Journal of Psychiatry.

Scientists Found a Way to Help the Eye Repair Itself by Blocking a Single Protein What if damaged eyes could one day repair themselves instead of losing vision permanently? Scientists are exploring this possibility after identifying a protein that may prevent the retina from regenerating. The retina is the light-sensitive layer at the back of the eye that allows us to see. In humans, damaged retinal nerve cells generally cannot grow back, making vision loss from diseases such as glaucoma and macular degeneration extremely difficult to reverse. But some animals, including zebrafish, can naturally repair their retinas after injury. Scientists have been trying to understand why humans lack this ability. Researchers have identified a protein called PROX1 that appears to act as a barrier to retinal regeneration. By blocking this protein, scientists were able to encourage retinal support cells in mice to change their behavior and help rebuild damaged light-sensitive tissue. The findings suggest that the eye may retain some of the biological tools needed for repair, but natural barriers prevent those tools from being activated. If researchers can safely apply this approach to humans, it could open new possibilities for treating certain types of vision loss. However, there is an important limitation: these findings do not mean that scientists can already restore eyesight in humans. The research was conducted in mice, and further studies are needed to determine whether the approach is safe and effective in people. Still, the discovery offers an exciting new direction for eye research. Instead of simply trying to protect the remaining vision, future treatments might one day help the eye rebuild damaged tissue from within. Source: Kim, M., Lee, E. J., & Kim, J. W. PROX1 inhibition restores vision through retinal neural regeneration. Nature Communications.

3D-PRINTED MEAT IS NOW SOLD IN U.S. GROCERY STORES — HERE’S WHAT YOU SHOULD KNOW Meat made with a 3D printer is entering the American food market, and it looks surprisingly similar to traditional meat. But there is an important difference: these products are made from plants, not animals. Israeli food technology company Steakholder Foods has introduced its Perfecta brand to grocery retailers in the northeastern United States. Its product range includes plant-based versions of steak, filet mignon, chicken breast, salmon patties, and white fish patties. The company uses a special process called Fused Paste Layering to build food products layer by layer. Ingredients containing plant proteins, including soy, wheat, and rice, are shaped to recreate the texture, structure, and marbled appearance of conventional meat. The aim is to offer meat-like foods without raising animals or using lab-grown animal cells. However, looking like meat does not necessarily mean having the same nutritional value. According to the reported figures, a plant-based salmon patty contains around 8 grams of protein per 100 grams, while natural salmon provides roughly 20 grams. The exact nutritional content depends on the product, making it important to check the label. The launch has also raised questions about how clearly these foods should be presented to shoppers. The products are marketed as plant-based meat alternatives, but the use of 3D-printing technology may not be prominently mentioned on the front of the packaging. This does not automatically mean the labeling is misleading. However, as new food technologies enter supermarkets, consumers may want clearer information about how their food is produced, what ingredients it contains, and how its nutritional value compares with conventional alternatives. Would you be willing to eat 3D-printed, plant-based meat, or would you stick with traditional meat? Source: Inc. Magazine (2026), A New Plant-Based Meat Brand Is Bringing 5 Types of 3D-Printed Food to U.S. Shoppers.

A DEADLY MOLD THAT ATTACKS THE BRAIN IS ON THE RISE — AND EVEN HEALTHY PEOPLE ARE AT RISK A rare but dangerous mold that can cause deadly brain infections is being detected more frequently in the United States. Known as Cladophialophora bantiana, this fungus can enter the body and reach the brain, where it may form serious pockets of infection called brain abscesses. The most alarming part? Researchers estimate that the infection kills around 60% to 70% of affected patients, even when they receive powerful antifungal medicines and surgery. What makes this fungus especially concerning is that about half of reported patients have no known condition that weakens their immune system. Scientists believe the mold may enter the body through breathing in fungal particles or through wounds in the skin. It may then spread through the bloodstream to the brain. However, researchers still do not fully understand where people are exposed to this dangerous fungus. Now, scientists have discovered another worrying sign. A recent report from the US Centers for Disease Control and Prevention (CDC) found a sharp rise in detections at a University of Washington reference laboratory. After recording roughly one to five cases per year in earlier years, the laboratory detected eight cases in 2024 and 14 in 2025. Researchers also found that the increase could not be explained simply by more testing. Despite its danger, this infection remains difficult to diagnose because its symptoms can resemble those of other brain conditions. By the time doctors identify the fungus, the infection may already be severe. Researchers are now facing an important question: Why are more cases being detected, and what is allowing this rare fungus to cause such devastating infections? Although these findings are concerning, the report does not mean that the fungus is spreading everywhere or that the general public faces an immediate widespread threat. More research is needed to understand the rise in detections, identify environmental sources, and improve early diagnosis. Source: Nelson, M. T., Truong, T. T., Bourassa, L. A., Smith, D. J., & Lieberman, J. A. (2026). Notes from the Field: Molecular Detections of Cladophialophora bantiana at a Clinical Reference Laboratory — United States, 2009–2026. Morbidity and Mortality Weekly Report (CDC).

Scientists have discovered that COVID-19 can directly infect key brain cells responsible for dopamine production, driving them into an aged, 'zombie-like' state. Researchers have uncovered a striking biological mechanism explaining why many individuals experience persistent brain fog, chronic fatigue, and loss of motivation following a COVID-19 infection. Studies demonstrate that SARS-CoV-2 can directly target midbrain dopamine neurons—the specialized cells responsible for regulating movement, focus, and reward pathways. Upon infection, these neurons stop functioning normally and enter a state known as cellular senescence. Rather than dying, the infected dopamine cells become non-functional 'zombie' cells, halting dopamine production while actively secreting chemical signals that trigger ongoing localized inflammation. This unexpected transformation mirrors biological pathways commonly seen in age-related neurodegenerative conditions like Parkinson's disease. By proving that dopamine neurons are uniquely susceptible to the virus, the findings provide a tangible target for medical interventions. Encouragingly, laboratory screens revealed that certain FDA-approved medications can prevent infection and rescue these damaged cells, opening promising new avenues for treating lingering neurological symptoms in long COVID patients. source: Yang, L., Kim, T. W., Han, Y., Nair, M. S., Harschnitz, O., Zhu, J., Wang, P., Koo, S. Y., Lacko, L. A., ... Chen, S. SARS-CoV-2 infection causes dopaminergic neuron senescence. Cell Stem Cell, 31(2), 196-211.